Géraldine Descamps

1.5k citations

30 papers · 1.1k indexed · h-index 20

Co-authors: Catherine Pellat‐Deceunynck Martine Amiot Régis Bataille Philippe Moreau Sophie Maïga Steven Le Gouill Patricia Gomez‐Bougie Gaëtan Jégo
Topics: Multiple Myeloma Research and Treatments (17 papers)Ubiquitin and proteasome pathways (11 papers)Protein Degradation and Inhibitors (6 papers)
Cited by: Hematology Oncology Immunology
Journals: SHILAP Revista de lepidopterologíaBlood The Journal of Immunology
Partner nations: France Switzerland Germany

In The Last Decade

Géraldine Descamps

29 papers receiving 1.0k citations

Peers

Countries citing papers authored by Géraldine Descamps

Since Specialization

Citations

This map shows the geographic impact of Géraldine Descamps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Descamps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Descamps more than expected).

Fields of papers citing papers by Géraldine Descamps

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Descamps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Descamps. The network helps show where Géraldine Descamps may publish in the future.

Co-authorship network of co-authors of Géraldine Descamps

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Descamps. A scholar is included among the top collaborators of Géraldine Descamps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Descamps. Géraldine Descamps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target 2025 ·Leukemia ·(unknown),Sophie Maïga,(unknown),Christelle Dousset,Agnès Moreau‐Aubry,Céline Bellanger,François Guillonneau,Géraldine Descamps,(unknown),Ohyun Kwon,(unknown),Philippe Moreau,David Chiron,Catherine Pellat‐Deceunynck,Cyrille Touzeau,Patricia Gomez‐Bougie	0
2	A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics 2023 ·Blood ·(unknown),Géraldine Descamps,Céline Bellanger,Christelle Dousset,Sophie Maïga,Jean-Baptiste Alberge,(unknown),(unknown),Stéphane Minvielle,(unknown),Catherine Godon,Yannick Le Bris,Benoît Tessoulin,Martine Amiot,Patricia Gomez‐Bougie,Cyrille Touzeau,Philippe Moreau,David Chiron,Agnès Moreau‐Aubry,Catherine Pellat‐Deceunynck	7
3	Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes 2020 ·Cell Death and Disease ·(unknown),Sophie Maïga,Cyrille Touzeau,Céline Bellanger,(unknown),Géraldine Descamps,Laurent Maillet,Philippe Moreau,Catherine Pellat‐Deceunynck,Patricia Gomez‐Bougie,Martine Amiot	34
4	Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells 2019 ·Frontiers in Oncology ·Benoît Tessoulin,Géraldine Descamps,Christelle Dousset,Martine Amiot,Catherine Pellat‐Deceunynck	24
5	Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways 2018 ·Journal of Hematology & Oncology ·Benoît Tessoulin,Agnès Moreau‐Aubry,Géraldine Descamps,Patricia Gomez‐Bougie,Sophie Maïga,Alban Gaignard,David Chiron,Emmanuelle Ménoret,Steven Le Gouill,Philippe Moreau,Martine Amiot,Catherine Pellat‐Deceunynck	35
6	Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells 2017 ·International Journal of Molecular Sciences ·(unknown),Géraldine Descamps,Sophie Maïga,Benoît Tessoulin,(unknown),(unknown),David Chiron,Philippe Moreau,Steven Le Gouill,Martine Amiot,Catherine Pellat‐Deceunynck,Agnès Moreau‐Aubry	3
7	RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormal myeloma cells independently of the p53 pathway 2014 ·BMC Cancer ·Sylvanie Surget,Géraldine Descamps,Carole Brosseau,Vincent Normant,Sophie Maïga,Patricia Gomez‐Bougie,(unknown),Catherine Godon,Marie C. Béné,Philippe Moreau,Steven Le Gouill,Martine Amiot,Catherine Pellat‐Deceunynck	19
8	Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells 2013 ·Blood Cancer Journal ·David Chiron,Sophie Maïga,Sylvanie Surget,Géraldine Descamps,Patricia Gomez‐Bougie,S Traoré,Nelly Robillard,Philippe Moreau,Steven Le Gouill,R Bataille,Martine Amiot,Catherine Pellat‐Deceunynck	24
9	Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells 2012 ·Cancer Research ·Sylvanie Surget,David Chiron,Patricia Gomez‐Bougie,Géraldine Descamps,Emmanuelle Ménoret,Régis Bataille,Philippe Moreau,Steven Le Gouill,Martine Amiot,Catherine Pellat‐Deceunynck	58
10	Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells 2012 ·Blood Cells Molecules and Diseases ·David Chiron,Sophie Maïga,Géraldine Descamps,Philippe Moreau,Steven Le Gouill,Séverine Marionneau‐Lambot,(unknown),Jérôme Moreaux,Bernard Klein,Régis Bataille,Martine Amiot,Catherine Pellat‐Deceunynck	22
11	The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction 2012 ·British Journal of Cancer ·Géraldine Descamps,Patricia Gomez‐Bougie,Jérôme Tamburini,Alexa S. Green,Didier Bouscary,Sophie Maïga,Philippe Moreau,Steven Le Gouill,Catherine Pellat‐Deceunynck,Martine Amiot	46
12	TLR9 Ligand Induces the Generation of CD20+ Plasmablasts and Plasma Cells from CD27+ Memory B-Cells 2011 ·SHILAP Revista de lepidopterología ·(unknown),David Chiron,Géraldine Descamps,Gaëtan Jégo,Martine Amiot,Catherine Pellat‐Deceunynck	22
13	A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines 2010 ·Haematologica ·Jérôme Moreaux,Bernard Klein,Régis Bataille,Géraldine Descamps,Sophie Maïga,Dirk Hose,(unknown),Anna Jauch,Thierry Rème,M Jourdan,Martine Amiot,Catherine Pellat‐Deceunynck	124
14	A humanised anti-IGF-1R monoclonal antibody (AVE1642) enhances Bortezomib-induced apoptosis in myeloma cells lacking CD45 2009 ·British Journal of Cancer ·Géraldine Descamps,Patricia Gomez‐Bougie,Corinne Venot,Philippe Moreau,Régis Bataille,Martine Amiot	35
15	IL-21 Stimulates Human Myeloma Cell Growth through an Autocrine IGF-1 Loop 2008 ·The Journal of Immunology ·Emmanuelle Ménoret,Sophie Maïga,Géraldine Descamps,Catherine Pellat‐Deceunynck,Caroline Fraslon,(unknown),Philippe Moreau,Régis Bataille,Martine Amiot	30
16	New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines 2008 ·Bioorganic & Medicinal Chemistry ·Laïla El Kihel,Monique Clément,Marc‐Antoine Bazin,Géraldine Descamps,(unknown),Sylvain Rault	31
17	CD45neg but Not CD45pos Human Myeloma Cells Are Sensitive to the Inhibition of IGF-1 Signaling by a Murine Anti-IGF-1R Monoclonal Antibody, mAVE1642 2006 ·The Journal of Immunology ·Géraldine Descamps,Soraya Wuillème‐Toumi,Valérie Trichet,Corinne Venot,Laurent Debüssche,Thierry Hercend,M. Collette,Nelly Robillard,Régis Bataille,Martine Amiot	32
18	Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors 2006 ·Leukemia ·Gaëtan Jégo,Régis Bataille,(unknown),Géraldine Descamps,Catherine Pellat‐Deceunynck	134
19	The Magnitude of Akt/Phosphatidylinositol 3′-Kinase Proliferating Signaling Is Related to CD45 Expression in Human Myeloma Cells 2004 ·The Journal of Immunology ·Géraldine Descamps,Catherine Pellat‐Deceunynck,(unknown),Régis Bataille,Nelly Robillard,Martine Amiot	34
20	Increased expression of liver PKC α in hypoinsulinemic diabetic rats: a post-translational effect 1998 ·Molecular and Cellular Endocrinology ·(unknown),(unknown),Mohamed Amessou,Géraldine Descamps,Bernard Desbuquois,Jean‐Pierre Clot,D. Durand	2

About Géraldine Descamps

Géraldine Descamps is a scholar working on Hematology, Molecular Biology and Oncology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (17 papers), Ubiquitin and proteasome pathways (11 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Hematology (429 citations), Oncology (350 citations) and Immunology (253 citations). Géraldine Descamps has collaborated with scholars based in France, Switzerland and Germany. Frequent co-authors include Catherine Pellat‐Deceunynck, Martine Amiot, Régis Bataille, Philippe Moreau, Sophie Maïga, Steven Le Gouill, Patricia Gomez‐Bougie, Gaëtan Jégo, Benoît Tessoulin and David Chiron. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact